XTL BIOPHARMACEUTICALS LTD.
Patent Owner
Stats
- 0 US PATENTS IN FORCE
- 2 US APPLICATIONS PENDING
- Feb 15, 2018 most recent publication
Details
- 0 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 99 Total Citation Count
- May 13, 2003 Earliest Filing
- 12 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2018/0043,016 PHARMACEUTICAL COMPOSITIONS COMPRISING 0.25 MG DOSE OF SYNTHETIC HUMAN PEPTIDES FOR TREATING SYSTEMIC LUPUS ERYTHEMATOSUSAug 10, 17Feb 15, 18[A61K, C07K]
2018/0043,017 PHARMACEUTICAL COMPOSITIONS COMPRISING 0.5 MG DOSE OF SYNTHETIC HUMAN PEPTIDES FOR TREATING SYSTEMIC LUPUS ERYTHEMATOSUSAug 10, 17Feb 15, 18[A61K]
Recent Patents
- No Recent Patents to Display
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
8143276 4-thio substituted quinoline and naphthyridine compoundsExpiredAug 22, 07Mar 27, 12[A61K, C07D]
8048889 3,4-disubstituted coumarin and quinolone compoundsExpiredMar 29, 05Nov 01, 11[A61K, A01N, C07D]
7923004 4-ethynyl pyrazole derivative compounds and methods for treatment of HCVExpiredOct 15, 07Apr 12, 11[A61K]
7731949 4-ethynyl pyrazole derivative compounds and methods for treatment of HCVWithdrawnOct 15, 07Jun 08, 10[A61K]
2005/0260,195 Treatment of hepatitis B virus infection with human monoclonal antibodiesAbandonedFeb 14, 05Nov 24, 05[A61K, C12Q]
2005/0069,865 Synthetic hcv envelope proteins and their use for vaccinationAbandonedSep 17, 04Mar 31, 05[C07H, A61K, C12Q, C12N, C07K]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.